Dr. Agarwal's Health Care
add_icon

Dr. Agarwal's Health Care

501.95
+1.70
(0.34%)
Market Cap
₹15,885.21 Cr
PE Ratio
109.02
Volume
69,194.00
Day High - Low
₹505.65 - ₹498.15
52W High-Low
₹568.00 - ₹327.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
15,885.21 Cr
EPS
2.80
PB Ratio
8.20
Book Value
61.01
EBITDA
502.40
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
5.73
Debt to Equity
0.60
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Dr. Agarwal's Health Care Limited allotted 2,99,122 equity shares under ESOP scheme 2022, increasing paid-up capital to ₹31.65 crores with shares exercised at ₹84.93 and ₹129.88.
neutral
Dr. Ashvin Agarwal Transfers 9.4 Lakh Shares to Dr. Ashar Agarwal in Promoter Gift TransactionDec 06, 2025
Dr. Ashvin Agarwal transferred 9,40,578 shares (0.30% stake) of Dr. Agarwal's Health Care Limited to Dr. Ashar Agarwal through an inter-se promoter transfer by way of gift on December 4, 2025. The transaction reduced Dr. Ashvin Agarwal's holding from 4.76% to 4.46% in the healthcare company, representing an internal restructuring within the promoter group.
neutral
Dr. Agarwal's Health Care Limited has issued a postal ballot notice seeking member approval to appoint M/s. S.R. Batliboi & Associates LLP as statutory auditors, replacing M/s. Deloitte Haskins & Sells who resigned on November 12, 2025. The e-voting period runs from November 18 to December 17, 2025, with the proposed auditor fee set at ₹52.50 lakh for FY 2025-26, as part of pre-merger alignment activities with subsidiary Dr. Agarwal's Eye Hospital Limited.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,062.60
#1 1,03,366.47
75.17
7,184.10
#1 28.65
1,076
#1 74.34
43.77
7,129.50
1,02,511.27
59.14
#1 21,994.30
14.76
#1 1,505
24.84
48.16
914.75
69,059.80
65.35
7,849.70
13.25
809
70.27
54.68
1,921.10
39,259.75
46.76
5,575.00
12.29
790
30.03
55.09
1,217.10
32,714.48
57.06
3,771.40
12.59
481
21.10
57.57
613.90
31,807.45
86.09
4,286.70
15.12
337
14.65
44.69
632.25
25,298.78
69.30
3,067.00
21.98
415
-40.35
42.45
501.95
#8 15,885.21
#10 109.02
#8 1,757.00
#2 27.64
#9 110
#2 71.36
48.66
5,764.00
13,994.08
#1 27.37
599.90
11.69
58
16.17
39.25
1,318.90
13,394.64
52.38
1,566.90
17.46
244
-4.30
42.37

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
27.64 %
Net Income Growth
15.98 %
Cash Flow Change
4.14 %
ROE
-16.84 %
ROCE
-16.24 %
EBITDA Margin (Avg.)
-3.22 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
345
369
410
429
443
476
501
507
Expenses
244
241
300
310
316
332
360
363
EBITDA
101
128
110
119
128
144
141
144
Operating Profit %
27 %
31 %
26 %
26 %
27 %
28 %
26 %
27 %
Depreciation
43
47
56
57
58
60
63
68
Interest
22
27
27
28
28
25
25
23
Profit Before Tax
36
54
27
33
41
59
54
54
Tax
13
13
9
12
13
16
16
17
Net Profit
23
41
18
21
28
43
38
37
EPS in ₹
1.94
1.39
0.43
0.45
0.73
1.04
0.95
0.94

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
787
1,026
1,825
2,753
3,672
Fixed Assets
575
702
1,293
1,746
2,523
Current Assets
155
228
310
759
794
Capital Work in Progress
11
28
99
118
153
Investments
0
0
34
471
264
Other Assets
201
296
399
418
731
Total Liabilities
787
1,026
1,825
2,753
3,672
Current Liabilities
150
206
301
400
478
Non Current Liabilities
438
586
865
974
1,267
Total Equity
199
234
659
1,380
1,927
Reserve & Surplus
177
206
622
1,330
1,835
Share Capital
7
7
8
9
32

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-56
17
44
27
-15
-8
Investing Activities
-85
-46
-155
-509
-914
-750
Operating Activities
103
99
164
233
346
360
Financing Activities
-74
-37
35
303
553
382

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Jun 2025
Sept 2025
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
32.42 %
32.42 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
59.26 %
58.13 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
6.44 %
7.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
1.74 %
1.41 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
0.14 %
0.11 %
No of Share Holders
29
43
2,17,289
68,696
63,021
48,168

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 402.50 449.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 401.60 375.25
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 445.90 446.20
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 433.50 460.20
30 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2025 542.55 510.35

Announcements

Closure of Trading Window7 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 19, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 17, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 30, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 30, 2025
Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 30, 2025
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Board Meeting Intimation for Considering And Approving Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 22, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 14, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 26, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptSep 03, 2025
Letter Sent To Members Providing Weblink Of The Annual Report 2024-25Sep 03, 2025
Reg. 34 (1) Annual Report.Sep 02, 2025
Annual Report For Financial Year 2024-25 And Notice For 15Th Annual General MeetingSep 02, 2025
Annual Report For Financial Year 2024-25 And Notice For 15Th Annual General MeetingSep 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 27, 2025
Board Meeting Outcome for Approval Of Matters Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 16, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Board Meeting Outcome for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Aug 12, 2025
Update On Earnings Call For Quarter Ended June 30 2025Aug 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Jul 30, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJul 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 02, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Tata India Pharma & Healthcare Fund Direct-Growth
1.22%
-303572
-1.11%
-1.17%
Canara Robeco Focused Fund Direct - Growth
0.90%
-264025
-0.44%
-1.46%
Motilal Oswal Small Cap Fund Direct - Growth
4.35%
71634
0.26%
0.08%
LIC MF Infrastructure Fund Direct-Growth
0.00%
-38357
-0.18%
-0.31%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.72%
-2500
-0.03%
0.22%
PGIM India Healthcare Fund Direct-Growth
0.51%
-2500
-0.06%
-0.07%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
1962
0.02%
0.01%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
949
0.02%
0.01%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
710
0.02%
0.01%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.21%
692
0.02%
0.02%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.22%
663
0.01%
0.01%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
408
0.02%
0.01%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
300
0.02%
0.01%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.02%
299
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
176
0.02%
0.01%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.21%
122
0.02%
0.01%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.05%
-79
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.21%
50
0.02%
0.01%
SBI Nifty 500 Index Fund Direct-Growth
0.02%
-49
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.30%
-27
0.01%
0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.21%
23
0.02%
0.01%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
22
0.00%
0.00%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.02%
16
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
6
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
2
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
47.42
ATR(14)
Volatile
13.24
STOCH(9,6)
Neutral
61.55
STOCH RSI(14)
Neutral
73.02
MACD(12,26)
Bullish
0.69
ADX(14)
Weak Trend
8.00
UO(9)
Bearish
46.53
ROC(12)
Uptrend And Accelerating
0.45
WillR(14)
Neutral
-53.81